News By Tag
News By Location
Follow on Google News
Catalog Peptides Market Share, Size, Future Demand, and Emerging Trends
Considering the continued R&D on the subject, P&S Intelligence forecasts that the catalog peptides market will grow from $238.4 million in 2018 to $332.1 million by 2024, at a 5.8% CAGR between 2019 and 2024 (forecast period).
By: P&S Intelligence
Apart from drug development, peptides are important in antibody production, enzyme profiling, disease research, biomarker discovery, and therapeutics. Presently, drug development, antibody production, and enzyme profiling, which together make up the commercial applications, account for the highest production and consumption of peptides. Apart from pharmaceuticals, they are also used in cosmetics. For instance, collagen and elastin are widely used to make aging skin bulkier and fuller, while antimicrobial peptides are being used for melanin production and skin whitening.
This is also why among all the entities that produce and consume peptides, including contract manufacturing organizations (CMOs) and contract research organizations (CROs), pharmaceutical and biotechnology companies, and academic and research institutes, pharma and biotech companies are the most significant. With the growing prevalence of all types of diseases, the demand for peptide-based therapeutics is rising. For instance, collagen is not only used for skincare, but also in advanced wound care, in the form of collagen-based biologics and collagen dressing. Similarly, recent research on the GLP-1 peptide has signaled that it could be more effective in diabetes treatment since it can change its shape inside the body.
Due to such extensive R&D in this field, North America dominated the catalog peptides market (https://www.psmarketresearch.com/
Thus, with a better understanding of peptides and their functions inside the human body, the demand for them in disease diagnosis and treatment will boom.